Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. [electronic resource]
Producer: 20130225Description: 28-38 p. digitalISSN:- 1872-8421
- Adoptive Transfer -- methods
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antigens, CD -- metabolism
- Butadienes -- pharmacology
- CD4-Positive T-Lymphocytes -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Transformed
- Chronic Disease
- Coculture Techniques
- Cytokines -- metabolism
- Dose-Response Relationship, Drug
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Enzyme Inhibitors -- pharmacology
- Female
- Flow Cytometry
- Gene Expression -- immunology
- Interferon-alpha -- pharmacology
- Lipopolysaccharides -- pharmacology
- Macrophages -- drug effects
- Mice
- Mice, Inbred Strains
- Mice, Transgenic
- Microglia -- drug effects
- Myelin Proteolipid Protein -- immunology
- Myelin-Oligodendrocyte Glycoprotein -- immunology
- Nitriles -- pharmacology
- Peptide Fragments -- immunology
- Receptors, Antigen, T-Cell -- genetics
- Secondary Prevention
- Severity of Illness Index
- T-Lymphocytes, Regulatory -- drug effects
- Time Factors
- Tritium
- Zymosan -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.